FdaApplication
NDA 216778
Identifiers
- fda_app_no: NDA216778
Properties
| Property | Value |
|---|---|
| applicant_name | ZYDUS LIFESCIENCES GLOBAL FZE |
| application_type | NDA |
| approval_date | 2024-07-18 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ZITUVIMET XR | METFORMIN HYDROCHLORIDE; SITAGLIPTIN | 1GM;100MG | TABLET, EXTENDED RELEASE;ORAL |
| ZITUVIMET XR | METFORMIN HYDROCHLORIDE; SITAGLIPTIN | 500MG;50MG | TABLET, EXTENDED RELEASE;ORAL |
| ZITUVIMET XR | METFORMIN HYDROCHLORIDE; SITAGLIPTIN | 1GM;50MG | TABLET, EXTENDED RELEASE;ORAL |
3 products